Puma Biotech (PBYI) Posts Q2 adj.-Loss of $1.17/Share
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Puma Biotech (NYSE: PBYI) reported Q2 EPS of ($1.17), $1.01 better than the analyst estimate of ($2.18).
For earnings history and earnings-related data on Puma Biotech (PBYI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Agree Realty (ADC) Tops Q3 FFO by 4c
- e-Future Information Technology (EFUT) Reports Q3 Loss of RMB0.75/Share
- Sonic Corp (SONC) Tops Q4 EPS by 1c, Offers FY17 Outlook
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!